In the news: FDA approves the first oral drug for reducing multiple sclerosis relapses
The FDA has approved the first oral medication for treating relapses of multiple sclerosis.
Content restricted. Requires subscription
The FDA has approved the first oral medication for treating relapses of multiple sclerosis.